Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07721025
PHASE2

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy

Sponsor: Lexeo Therapeutics

View on ClinicalTrials.gov

Summary

The purpose of Study LX2006-03, a multicenter, Phase 2, open-label, randomized, controlled study, is to evaluate the efficacy and safety of LX2006 gene therapy in participants with Friedreich ataxia (FA) cardiomyopathy (CM).

Official title: A Phase 2, Multicenter, Open-label, Randomized, Controlled Study of LX2006 Gene Therapy in Participants With Friedreich Ataxia Cardiomyopathy (SUNRISE-FA 2)

Key Details

Gender

All

Age Range

6 Years - Any

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2026-06-25

Completion Date

2032-06

Last Updated

2026-11-17

Healthy Volunteers

No

Interventions

GENETIC

LX2006

Adeno-associated viral vector encoding the FXN gene (AAVrh.10hFXN)

OTHER

Usual Care

Cohort 1: Participants ≥16 years of age with FA-CM Participants will receive usual care for 26 weeks before receiving treatment with LX2006 (single crossover).

Locations (22)

Arkansas Children's

Little Rock, Arkansas, United States

University of California San Diego

La Jolla, California, United States

Ataxia Center and HD Center of Excellence (UCLA)

Los Angeles, California, United States

University of South Florida

Tampa, Florida, United States

Indiana University

Indianapolis, Indiana, United States

Boston Children's Hospital

Boston, Massachusetts, United States

Mayo Clinic

Rochester, Minnesota, United States

Washington University School of Medicine

St Louis, Missouri, United States

Cincinnati Children's Hospital

Cincinnati, Ohio, United States

Hospital Universitário Walter Cantídio - Universidade Federal do Ceará

Fortaleza, Ceará, Brazil

Instituto D'Or de Pesquisa e Ensino - Hospital São Rafael

Salvador, Estado de Bahia, Brazil

Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG)

Belo Horizonte, Minas Gerais, Brazil

Campinas State University (UNICAMP)

Campinas, São Paulo, Brazil

UPC Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

Ribeirão Preto, São Paulo, Brazil

Centre hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada

Motol University Hospital and the Second Faculty of Medicine

Prague, Czechia

Institut de Cardiologie, Hôpital Pitié-Salpêtrière

Paris, France

University Hospital Tübingen, Department of Neurology

Tübingen, Baden-Wurttemberg, Germany

Federico II University

Naples, Italy, Italy

Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, Madrid, Spain

St. Bartholomew's Hospital

London, United Kingdom

Imperial College Healthcare NHS Trust

London, United Kingdom